COMBINATORIAL GENE THERAPY FOR BONE REGENERATION
骨再生组合基因疗法
基本信息
- 批准号:8050640
- 负责人:
- 金额:$ 31.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-03-01 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adenovirus VectorAdenovirusesBMP2 geneBasic ScienceBiologicalBiological ProcessBone DevelopmentBone RegenerationCalvariaCell Culture TechniquesCell Differentiation processCell LineCell ProliferationCephalicComplementary DNADefectDevelopmentDifferentiation and GrowthEventFGF2 geneFemurFibroblast Growth Factor ReceptorsFractureFracture HealingGene ExpressionGeneticHealedImplantIn VitroIndividualInjection of therapeutic agentLaboratoriesMAP Kinase GeneMarrowMeasuresMesenchymalModelingMutationNatural regenerationOsteoblastsOsteogenesisPathway interactionsPeptide Signal SequencesPlayPopulationPre-Clinical ModelProcessProtein IsoformsProtein SecretionReagentRegulationRetroviridaeRodent ModelRoleSignal TransductionSiteStem cellsStromal CellsSystemTestingTimeTranslational Researchbasebonebone healingcombinatorialcomparative efficacygene therapyhealingimprovedin vivolong bonenovelosteogenicosteoprogenitor celloverexpressionprogenitorregenerativerepairedresponseselective expressionsubcutaneousvector
项目摘要
DESCRIPTION (provided by applicant): Gene therapy approaches involving constitutive overexpression of cDNAs encoding individual BMPs can induce bone formation and partially repair cranial and long bone defects as shown by this laboratory. However, this strategy is limited by the availability of BMP-responsive osteoprogenitor/stem cells at the regeneration site and lack of control over the timing and duration of regenerative factor expression. The underlying hypothesis of this competitive renewal is that bone regeneration can be greatly improved if gene therapy is used to mimic the natural processes of bone development and fracture repair characterized by the participation of multiple growth/differentiation factors whose expression is under tight temporal control. Of particular importance are factors such as BMPs that may function as heterodimers to stimulate progenitor differentiation and FGF2 that controls progenitor proliferation. This project, which contains both translational and basic science components, will compare the efficacy of regenerative approaches in well-defined preclinical models as well as explore underlying mechanisms by achieving the following specific aims:
Aim 1. Evaluate actions of an adenovirus expressing FGF2 (AdFGF2) on osteoprogenitor cell proliferation and differentiation in vitro and in vivo with or without Ad BMPs. Hypothesis: AdFGF2 can expand the population of osteogenic precursors at regeneration sites to enhance bone formation.
Aim 2. Use inducible gene expression systems to control the timing, duration and sequence of osteogenic factor synthesis. Hypothesis: Enhanced control of osteogenesis can be achieved using regulated gene expression to control the timing, duration and sequence of proliferative versus osteoqenic signals.
This project will test novel regenerative concepts involving cooperative interactions between proliferative and osteogenic factors and temporal regulation of factor synthesis using simple rodent models. Approaches developed will provide proof of principle of the eventual development of new therapies for bone regeneration that mimic natural biological processes by providing temporal control over regenerative events.
描述(由申请人提供):如本实验室所示,涉及编码单个BMP的cDNA的组成型过表达的基因治疗方法可以诱导骨形成并部分修复颅骨和长骨缺损。然而,这种策略受到BMP-反应性骨祖细胞/干细胞在再生部位的可用性以及缺乏对再生因子表达的时间和持续时间的控制的限制。这种竞争性更新的基本假设是,如果基因治疗用于模拟骨发育和骨折修复的自然过程,其特征在于多种生长/分化因子的参与,其表达受到严格的时间控制,则可以大大改善骨再生。特别重要的是因子,如BMP,其可作为异源二聚体起作用以刺激祖细胞分化,和FGF 2,其控制祖细胞增殖。该项目包含转化和基础科学部分,将在明确的临床前模型中比较再生方法的功效,并通过实现以下具体目标探索潜在机制:
目标1。评价表达FGF 2的腺病毒(AdFGF 2)在体外和体内有或没有Ad BMP的情况下对骨祖细胞增殖和分化的作用。假设:AdFGF 2可以扩大再生部位的成骨前体细胞群,从而促进骨形成。
目标二。使用诱导基因表达系统来控制成骨因子合成的时间、持续时间和顺序。假设:通过调节基因表达来控制增殖信号与成骨信号的时间、持续时间和顺序,可以实现对骨生成的增强控制。
这个项目将测试新的再生概念,涉及合作之间的相互作用,增殖和成骨因子和时间调节因子合成使用简单的啮齿动物模型。所开发的方法将为最终开发用于骨再生的新疗法提供原理证明,该新疗法通过提供对再生事件的时间控制来模拟自然生物过程。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration.
- DOI:10.1177/154405910808700906
- 发表时间:2008-09
- 期刊:
- 影响因子:7.6
- 作者:Koh, J. T.;Zhao, Z.;Wang, Z.;Lewis, I. S.;Krebsbach, P. H.;Franceschi, R. T.
- 通讯作者:Franceschi, R. T.
Patterning expression of regenerative growth factors using high intensity focused ultrasound.
使用高强度聚焦超声对再生生长因子进行模式化表达。
- DOI:10.1089/ten.tec.2013.0518
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Wilson,ChristopherG;Martín-Saavedra,FranciscoM;Padilla,Frédéric;Fabiilli,MarioL;Zhang,Man;Baez,AlexanderM;Bonkowski,ChristopherJ;Kripfgans,OliverD;Voellmy,Richard;Vilaboa,Nuria;Fowlkes,JBrian;Franceschi,RennyT
- 通讯作者:Franceschi,RennyT
Temporal and spatial patterning of transgene expression by near-infrared irradiation.
- DOI:10.1016/j.biomaterials.2014.06.009
- 发表时间:2014-09
- 期刊:
- 影响因子:14
- 作者:Martin-Saavedra, Francisco M.;Cebrian, Virginia;Gomez, Leyre;Lopez, Daniel;Arruebo, Manuel;Wilson, Christopher G.;Franceschi, Renny T.;Voellmy, Richard;Santamaria, Jesus;Vilaboa, Nuria
- 通讯作者:Vilaboa, Nuria
The effects of Runx2 immobilization on poly (epsilon-caprolactone) on osteoblast differentiation of bone marrow stromal cells in vitro.
- DOI:10.1016/j.biomaterials.2010.01.029
- 发表时间:2010-04
- 期刊:
- 影响因子:14
- 作者:Zhang, Ying;Deng, Xiaopei;Scheller, Erica L.;Kwon, Tae-Geon;Lahann, Joerg;Franceschi, Renny T.;Krebsbach, Paul H.
- 通讯作者:Krebsbach, Paul H.
Acoustic droplet-hydrogel composites for spatial and temporal control of growth factor delivery and scaffold stiffness.
- DOI:10.1016/j.actbio.2013.03.027
- 发表时间:2013-07
- 期刊:
- 影响因子:9.7
- 作者:Fabiilli, Mario L.;Wilson, Christopher G.;Padilla, Frederic;Martin-Saavedra, Francisco M.;Fowlkes, J. Brian;Franceschi, Renny T.
- 通讯作者:Franceschi, Renny T.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Renny Theodore Franceschi其他文献
Renny Theodore Franceschi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Renny Theodore Franceschi', 18)}}的其他基金
Discoidin Domain Receptor 2, β1 Integrins and ECM Control of Bone Formation
Discoidin 结构域受体 2、β1 整合素和 ECM 对骨形成的控制
- 批准号:
10117775 - 财政年份:2021
- 资助金额:
$ 31.25万 - 项目类别:
Discoidin Domain Receptor 2, β1 Integrins and ECM Control of Bone Formation
Discoidin 结构域受体 2、β1 整合素和 ECM 对骨形成的控制
- 批准号:
10371109 - 财政年份:2021
- 资助金额:
$ 31.25万 - 项目类别:
Discoidin Domain Receptor 2, β1 Integrins and ECM Control of Bone Formation
Discoidin 结构域受体 2、β1 整合素和 ECM 对骨形成的控制
- 批准号:
10584467 - 财政年份:2021
- 资助金额:
$ 31.25万 - 项目类别:
Discoidin domain receptor 2, a novel regulator of bone regeneration
Discoidin 结构域受体 2,骨再生的新型调节剂
- 批准号:
9806949 - 财政年份:2019
- 资助金额:
$ 31.25万 - 项目类别:
Discoidin domain receptor 2, a novel regulator of bone regeneration
Discoidin 结构域受体 2,骨再生的新型调节剂
- 批准号:
9977158 - 财政年份:2019
- 资助金额:
$ 31.25万 - 项目类别:
MAP KINASE REGULATION OF OSTEOBLAST FUNCTION
成骨细胞功能的 MAP 激酶调节
- 批准号:
7903811 - 财政年份:2009
- 资助金额:
$ 31.25万 - 项目类别:
ABI PRISM 7700 SEQUENCE DETECTION SYSTEM
ABI PRISM 7700 序列检测系统
- 批准号:
6291371 - 财政年份:2001
- 资助金额:
$ 31.25万 - 项目类别:
GENE THERAPY APPROACH FOR ENGINEERING CRANIOFACIAL BONE
工程颅面骨的基因治疗方法
- 批准号:
6634669 - 财政年份:2000
- 资助金额:
$ 31.25万 - 项目类别:
GENE THERAPY APPROACH FOR ENGINEERING CRANIOFACIAL BONE
工程颅面骨的基因治疗方法
- 批准号:
2907661 - 财政年份:2000
- 资助金额:
$ 31.25万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 31.25万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 31.25万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 31.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 31.25万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 31.25万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 31.25万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 31.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 31.25万 - 项目类别:
Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 31.25万 - 项目类别:
Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 31.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)